Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Resectable Pancreatic Cancer 1 Rectal Neoplasms 1 Esophageal Neoplasms 1

Interventions

Oxaliplatin 47 Capecitabine 46 Fluorouracil 40 Leucovorin 30 Radiotherapy 25 Irinotecan 20 Chemoradiotherapy 14 Bevacizumab 14 Cetuximab 12 Neoadjuvant Therapy 11 Folfox protocol 11 Chemotherapy, Adjuvant 11 XELOX 10 Laparoscopy 10 Drug Therapy 9 Surgical Procedures, Operative 6 Robotic Surgical Procedures 5 Radiation 5 Mastectomy, Segmental 5 Surveys and Questionnaires 4 Radiotherapy, Intensity-Modulated 4 Panitumumab 4 Gemcitabine 4 FOLFOXIRI protocol 4 durvalumab 3 Simvastatin 3 Magnetic Resonance Spectroscopy 3 Indocyanine Green 3 tislelizumab 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Rectal Neoplasms × Chemoradiotherapy, Adjuvant × Clear all

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡